Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Doxofylline vs Procaterol in COPD
NCT06346691Phase 4Completed
- Sponsor
- Thammasat University
- Start
- Mar 2024
- Primary completion
- Oct 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of doxofylline in chronic obstructive pulmonary disease (COPD), sponsored by Thammasat University. Started Mar 2024; status: completed.
02
Drugs
doxofylline
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT06346691.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06346691.